Hepatitis D is a forgotten problem in hemodialysis patients in the world

Hepatitis Monthly

Volumn 8, Issue 1, 2008, Pages 9-10

  Alavian, Seyed Moayed ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RECOMBINANT ERYTHROPOIETIN;

DELTA AGENT HEPATITIS; EDITORIAL; EPIDEMIOLOGICAL DATA; FRANCE; HEMODIALYSIS PATIENT; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMIGRATION; INCIDENCE; INFECTION CONTROL; IRAN; PREVALENCE; PUBLIC HEALTH; SWEDEN; UNITED STATES; VACCINATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 44949173280     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. Taylor JM. Genetic organization and replication strategy of hepatitis delta virus. Semin Virol 1993; 4: 313-7.
2. Hadziyannis SJ. Review: hepatitis delta. J Gastroenterol Hepatol 1997; 12: 289-98.
3. London WT, Evans AA. The epidemiology of hepatitis viruses B, C, and D. Clin Lab Med 1996; 16: 251-71.
4. Ponzetto A, Forzani B, Parravicini PP, Hele C, Zanetti A, Rizzetto M. Epidemiology of hepatitis delta virus (HDV) infection. Eur J Epidemiol 1985; 1: 257-63.
5. Rizzetto M. Delta virus hepatitis. Adv Exp Med Biol 1989; 257: 205-9.
6. Alavian S, M, Fallabian F, Bagheri-Lankarani K. The Changing Epidemiology of Viral Hepatitis B in Iran. J Gastrointestin Liver Dis 2007; 16: 403-6.
7. Wong PN, Fung TT, Mak SK, Lo KY, Tong GM, Wong Y, et al. Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol 2005; 20: 1641-51.
8. Alavian SM, Mahdavi-Mazdeh M, Bagheri-Lankarani K. Hepatitis B and C in dialysis units in Iran, Changing the epidemiology. Hemodial Int 2008 (In Press).
9. Fabrizi F, Martin P, Lunghi G, Ponticelli C. Novel evidence on hepatitis B virus infection in dialysis. Int J Artif Organs 2001; 24: 8-16.
10. Rizzetto M, Verme G. Delta hepatitis-present status. J Hepatol 1985; 1: 187-93.
11. Roggendorf M, Gmelin K, Zoulek G, Wolf P, Schhpkoter U, Jilg W, et al. Epidemiological studies on the prevalence of hepatitis Delta virus infections in the Federal Republic of Germany. J Hepatol 1986; 2: 230-6.
12. Marinucci G, Di Giacomo C, Orchi N, Iannicelli G, Ferrazzi M, De Paolis P, et al. HBV and HDV infection in chronic hemodialysis treatment patients (in Italian). Riv Eur Sci Med Farmacol 1987; 9: 313-6.
13. Kharsa G, Degott C, Degos F, Carnot F, Potent F, Kreis H. Fulminant hepatitis in renal transplant recipients. The role of the delta agent. Transplantation 1987; 44: 221-3.
14. Gmelin K, Roggendorf M, Schlipkoter U. Delta infection in a hemodialyzed patient. J Infect Dis 1985; 151: 374.
15. Rezvan H, Ahmadi J, Farhadi M. A preliminary study on the prevalence of anti-HCV amongst healthy blood donors in Iran. Vox Sang 1994; 67: A100.
16. Pol S, Dubois F, Mattlinger B, Carnot F, Legendre C, Brechot C, et al. Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in France. Transplantation 1992; 54: 1096-7.
17. Alavian SM, Mostajabi P, Malekzadeh R, Azimi K, Vosough H, Sarrafi M, et al. Evaluation of Hepatitis B Transmission Risk Factors in Tehran Blood Donors (in Persian). Govaresh 2004; 3: 169-75.
18. Fabrizi F, Lunghi G, Martin P. Epidemiology of hepatitis delta virus (HDV) infection in the dialysis population. Int J Artif Organ 2002; 25: 8-17.